Preview

Колопроктология

Расширенный поиск

МИКРОСАТЕЛЛИТНАЯ НЕСТАБИЛЬНОСТЬ ПРИ КОЛОРЕКТАЛЬНОМ РАКЕ (обзор литературы)

https://doi.org/10.33878/2073-7556-2017-0-2-100-104

Полный текст:

Об авторах

Алексей Сергеевич Цуканов
ФГБУ «ГНЦК им.А.Н. Рыжих» Минздрава России
Россия


Ю. А. Шелыгин
ФГБУ «ГНЦК им.А.Н. Рыжих» Минздрава России
Россия


В. П. Шубин
ФГБУ «ГНЦК им.А.Н. Рыжих» Минздрава России
Россия


Список литературы

1. Семенов Д.А., Ачкасов С.И., Цуканов А.С. и соавт. Синдром Линча. От «семьи G» до ДНК-диагностики. Колопроктология. - 2014. - №3. - с. 57-61.

2. Федянин М.Ю., Трякин А.А., Тюляндин С.А. Роль микросателлитной нестабильности при раке толстой кишки. Онкологическая колопроктология. - 2012. - №3. - с. 19-25.

3. Цуканов А.С., Поспехова Н.И., Шубин В.П. и соавт. Дифференциальный диагноз синдрома Линча от других форм неполипозного колоректального рака среди российских пациентов. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. - 2014. - т. 24. - №2. - с. 78-84.

4. Чернышов С.В. Скрининг колоректального рака. Обзор литературы. Колопроктология. - 2009. -№ 2. - с. 55-59.

5. Янус Г.А., Корнилов А.В., Суспицын Е.Н. и соавт. Молекулярно-генетическая диагностика наследственного неполипозного рака толстой кишки. Сибирский онкологический журнал. - 2012. -№ 2. - с. 29-38.

6. Berg A., Armstrong K., Botkin J. et al. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med. - 2009 Jan; 11 (1): 35-41.

7. Dietmaier W., Wallinger S., Bocker T. et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer. Res. - 1997 Nov; 57 (21): 4749-56.

8. Engel C., Forberg C., Holinski-Feder E. et al. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int. J. Cancer. - 2006 Jan 1; 118 (1): 115-22.

9. Evans D.G., Walsh S., Hill J. et al. Strategies for identifying hereditary nonpolyposis colon cancer. Semin. Oncol. - 2007 Oct; 34 (5): 411-7.

10. Giardiello F., Allen J., Axilbund J. et al. Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Dis. Colon. Rectum. - 2014 Aug; 57 (8): 1025-48.

11. Gruber S. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology. - 2006 Feb; 130 (2): 577-87.

12. lonov Y., Peinado M., Malkhosyan S. et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colorectal carcinogenesis. Nature. - 1993 Jun 10; 363 (6429): 558-61.

13. Kakar S., Burgart L.J., Thibodeau S.N. et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer. - 2003 Mar 15; 97 (6): 1421-7.

14. Klingbiel D., Saridaki Z., Roth A. et al. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. Ann. Oncol. 2015 Jan; 26 (1): 126-32

15. Le D., Uram J., Wang H. et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N. Engl. J. Med. - 2015 Jun 25; 372 (26): 2509-20.

16. Lochhead P., Kuchiba A., Imamura Y. et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J. Natl. Cancer Inst. - 2013 Aug 7; 105 (15): 1151-6.

17. Lynch H.T., Shaw M.W., Magnuson C.W. et al. Hereditary factors in cancer: study of two large Midwestern kindreds. Arch. Intern. Med. - 1966 Feb; 117 (2): 206-12.

18. Makrodouli E., Oikonomou E., Koc M. et al. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol. Cancer. - 2011 Sep 23; 10: 118.

19. Nakaji Y., Oki E., Nakanishi R. et al. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.J. Cancer. Res. Clin. Oncol. - 2016 Sep 26. [Epub ahead of print].

20. Peltomaki P., Aaltonen. L.A., Sistonen P. et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. - 1993 May 7; 260 (5109): 810-2.

21. Potter J., Lindor N. Genetics of colorectal cancer. Springer. - 2008. - р. 185.

22. Rahner N., Steinke V., Schlegelberger B. et al. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2). Eur. J. Hum. Genet. - 2010 Sep; 18 (9).

23. Roth A.D., Tejpar S., Delorenzi M. et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J. Clin. Oncol. - 2010 Jan 20; 28 (3): 466-74.

24. Suraweera N., Duval A., Reperant M. et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology. - 2002 Dec; 123 (6): 1804-11.

25. Thibodeau S.N., Bren G., Schaid D.J. Microsalellite instability in cancer of the proximal colon. Science. - 1993 May 7; 260 (5109): 816-9.

26. Thibodeau S., French A., Cunningham J. et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer. Res. - 1998 Apr 15; 58 (8): 1713-8.

27. Umar A., Boland C., Terdiman J. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl. Cancer Inst. - 2004 Feb 18; 96 (4): 261-8.

28. Vasen H.F., Mecklin J.P., Khan P.M. et al. International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum. - 1991 May; 34 (5): 424-5.

29. Vasen H., Moslein G., Alonso A. et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J. Med. Genet. - 2007 Jun; 44 (6): 353-62.

30. Vasen H.F., Watsan P., Mecklin J.P. et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. - 1999 Jun; 116 (6): 1453-6.

31. Venderbosch S., Nagtegaal I., Maughan T. et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin. Cancer Res. - 2014. - 15; 20 (20): 5322-30.

32. Warthin A.S. Heredity with reference to carcinoma as shown by the study of the cases examined in the Pathological Laboratory of the University of Michigan, 1895-1912. Arch. Int. Med. - 1913; 12: 546-55.

33. Wellbrock C., Karasarides M., Marais R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell. Biol. - 2004 Nov; 5 (11): 875-85.

34. Yuan L., Chi Y., Chen W. et al. Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency. Int. J. Clin. Exp. - Med. 2015 Nov 15; 8 (11): 20988-1000.


Для цитирования:


Цуканов А.С., Шелыгин Ю.А., Шубин В.П. МИКРОСАТЕЛЛИТНАЯ НЕСТАБИЛЬНОСТЬ ПРИ КОЛОРЕКТАЛЬНОМ РАКЕ (обзор литературы). Колопроктология. 2017;(2):100-104. https://doi.org/10.33878/2073-7556-2017-0-2-100-104

For citation:


Tsukanov A.S., Shelygin Yu.A., Shubin V.P. MICROSATELLITE INSTABILITY IN COLORECTAL CANCER (review). Koloproktologia. 2017;(2):100-104. (In Russ.) https://doi.org/10.33878/2073-7556-2017-0-2-100-104

Просмотров: 922


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2073-7556 (Print)
ISSN 2686-7303 (Online)